Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gerken

Showing results (171-180 of 175) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 175 results.
BMC Gastroenterology|October 7, 2025
Heterogeneity of treatment preferences in the absence of guideline recommendations - a case vignette study in colorectal cancer tumor boards in Germany, Austria and SwitzerlandJohannes Soff, Stefan Rolf Benz, Christoph Kowalski, et al.
Journal of Cancer Research and Clinical Oncology|March 12, 2026
Prognostic factors for lymph node infestation, long-term survival and recurrence rates in patients with vaginal cancer: a population-based study in GermanyShirin Wenning, Michael Gerken, Thomas Papathemelis, et al.
Current Oncology (Toronto, Ont.)|October 25, 2024
Health-Related Quality of Life and Treatment Satisfaction of Patients with Malignant IDH Wild-Type Gliomas and Their CaregiversAnna Fischl, Michael Gerken, Patricia Lindberg-Scharf, et al.
International Journal of Cancer|March 9, 2026
A cost-effectiveness analysis of breast cancer treatment in certified versus non-certified hospitals in GermanyMin-Wai Lwin, Olaf Schoffer, Christoph Streissnig, et al.
BMC Cancer|December 7, 2016
Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011Olaf Schoffer, Stefanie Schülein, Gerlinde Arand, et al.
Pageof 18

Showing results (171-180 of 175) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 175 results.
BMC Gastroenterology|October 7, 2025
Heterogeneity of treatment preferences in the absence of guideline recommendations - a case vignette study in colorectal cancer tumor boards in Germany, Austria and SwitzerlandJohannes Soff, Stefan Rolf Benz, Christoph Kowalski, et al.
Journal of Cancer Research and Clinical Oncology|March 12, 2026
Prognostic factors for lymph node infestation, long-term survival and recurrence rates in patients with vaginal cancer: a population-based study in GermanyShirin Wenning, Michael Gerken, Thomas Papathemelis, et al.
Current Oncology (Toronto, Ont.)|October 25, 2024
Health-Related Quality of Life and Treatment Satisfaction of Patients with Malignant IDH Wild-Type Gliomas and Their CaregiversAnna Fischl, Michael Gerken, Patricia Lindberg-Scharf, et al.
International Journal of Cancer|March 9, 2026
A cost-effectiveness analysis of breast cancer treatment in certified versus non-certified hospitals in GermanyMin-Wai Lwin, Olaf Schoffer, Christoph Streissnig, et al.
BMC Cancer|December 7, 2016
Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011Olaf Schoffer, Stefanie Schülein, Gerlinde Arand, et al.
Pageof 18